Chlamydia pneumoniae in acute otitis media

Pediatric Infectious Disease Journal

Volumn 16, Issue 9, 1997, Pages 858-862

  Block, Stan L ^a,g   Hammerschlag, Margaret R ^b   Hedrick, James ^a   Tyler, Ron ^a   Smith, Alan ^a   Roblin, Patricia ^b   Gaydos, Charlotte ^c   Pham, Dien ^c   Quinn, Thomas C ^c   Palmer, Robert ^d   Mccarty, James ^e,f  

^a Kentucky Pediatric Research Institute   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d ABBOTT LABORATORIES   (United States)

^e Hill Top Research Inc   (United States)

^f Hilltop Research Inc   (United States)

^g NONE   (United States)

Author keywords

Acute otitis media; Children; Chlamydia pneumoniae

Indexed keywords

AEROBIC METABOLISM; ARTICLE; BACTERIUM CULTURE; CHILD; CHLAMYDOPHILA PNEUMONIAE; ENZYME ACTIVITY; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORAXELLA CATARRHALIS; OTITIS MEDIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BODY FLUIDS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; EAR, MIDDLE; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OTITIS MEDIA WITH EFFUSION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEX DISTRIBUTION; UNITED STATES;

EID: 17644434242     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199709000-00008     Document Type: Article

References (25)

1. Giebink GS, Canafax DM, Kempthorne J. Antimicrobial treatment of acute otitis media. J Pediatr 1991;119:495-500.
2. Klein JO. Microbiological efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 1993;12:973-5.
3. Pukander JS, Jero JP, Kaprio EA, Sorri MJ. Clarithromycin us amoxicillin suspension in the treatment of pediatric patients with acute otitis media. Pediatr Infect Dis J 1993; 12:8118-21.
4. Hoberman A, Paradise J, Block SL. Amoxicillin clavulanate therapy for penicillin-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 1996;15:955-61.
5. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
6. Ruuskanen O, Arola M, Heikkinem T, Ziegler T. Viruses in acute otitis media; increasing evidence for clinical significance. Pediatr Infect Dis J 1991;10:425-7.
7. Sung BS, Chonmaintree T, Broemeling LD, et al. Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media. Clin Infect Dis 1993;17:38-42.
8. Post JC, Preston RA, Aul JJ, et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 1995;273:1598-604.
9. Klein JO, Teele DW. Isolation of viruses and mycoplasmas from middle ear effusions: a review. Ann Otol Rhinol Laryngol 1976;85:S140-4.
10. Grayston JT, Kuo CC, Wang SP, et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-8.
11. Bourke JS, Lightfoot NF. Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis. Thorax 1995;50(Suppl 1):S43-8.
12. Block SL, Hedrick JA, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995;14:471-7.
13. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994;148:727-32.
14. Ogawa H, Kasuhiro K, Kazuyama Y. Recovery of Chlamydia pneumoniae in six patients with otitis media with effusion. J Laryngol Otol 1992;106:490-2.
15. Goo YA, Hori MK, Voorhies JH, Kuo CC, Wang SP, Campbell LA. Failure to detect Chlamydia pneumoniae in ear fluids from children with otitis media. Pediatr Infect Dis J 1995;14:1000-1.
16. Roblin PM, Dumormay W, Hammerschlag MR. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1992;30:1968-71.
17. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994;32:903-5.
18. Davis D, Summersgill JT, LeBar W, Mason E. Failure to detect Chlamydia pneumoniae in middle ear aspirates from patients with otitis media with effusion [Abstract C 351]. Presented at the 97th general meeting of the American Society for Microbiology, Miami Beach, FL, May 4 to 8, 1997.
19. Chang MJ, Rodriguez WJ, Mohla C. Chlamydia trachomatis in otitis media in children. Pediatr Infect Dis J 1982;1:95-7.
20. Hammerschlag MR, Hammerschlag PE, Alexander ER. The role of Chlamydia trachomatis in middle ear effusions in children. Pediatrics 1980;66:615-7.
21. Blackston ML, Lovchik JC, Gray WC. Presence of Chlamydia trachomatis in tympanocentesis fluid assessed by immunofluorescence microscopy and cell culture. Otolaryngol Head Neck Surg 1989;100:348-9.
22. Dawson VM, Coelen RJ, Murphy S, Graham D, Dyer H, Sunderman J. Microbiology of chronic otitis media with effusion among Australian aboriginal children: role of Chlamydia trachomatis. Aust J Exp Biol Med Sci 1985;63:99-107.
23. Hammerschlag MR. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob Agents Chemother 1994;38:1873-8.
24. Roblin PM, Montalban G, Hammerschlag MR. Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrob Agents Chemother 1994;38:1588-9.
25. Pichichero ME, Mclinn S, Aronovitz G, et al. Cefprozil treatment of persistent and recurrent acute otitis media. Pediatr Infect Dis J 1997;16:471-8.